Norinchukin Bank, The Bio Rad Laboratories, Inc. Transaction History

Norinchukin Bank, The

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$304.11 - $351.99 $2,128 - $2,463	-7 Reduced 1.0%	693 $239,000
Q4 2023 Feb 13, 2024	SELL	$269.37 - $365.04 $6,734 - $9,126	-25 Reduced 3.45%	700 $226,000
Q3 2023 Nov 13, 2023	BUY	$350.25 - $422.63 $253,931 - $306,406	725 New	725 $259,000
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $100,657 - $136,192	-280 Reduced 22.33%	974 $369,000
Q1 2023 May 12, 2023	BUY	$418.69 - $503.0 $18,003 - $21,629	43 Added 3.55%	1,254 $600,000
Q4 2022 Feb 13, 2023	SELL	$351.71 - $456.01 $74,562 - $96,674	-212 Reduced 14.9%	1,211 $509,000
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $47,860 - $65,338	116 Added 8.88%	1,423 $594,000
Q2 2022 Aug 10, 2022	SELL	$463.67 - $597.16 $307,413 - $395,917	-663 Reduced 33.65%	1,307 $647,000
Q1 2022 May 12, 2022	BUY	$524.57 - $735.42 $78,685 - $110,313	150 Added 8.24%	1,970 $1.11 Million
Q4 2021 Feb 10, 2022	SELL	$708.84 - $794.68 $8,506 - $9,536	-12 Reduced 0.66%	1,820 $1.38 Million
Q3 2021 Nov 09, 2021	BUY	$657.71 - $825.77 $31,570 - $39,636	48 Added 2.69%	1,832 $1.37 Million
Q2 2021 Aug 11, 2021	SELL	$576.64 - $649.04 $4,613 - $5,192	-8 Reduced 0.45%	1,784 $1.15 Million
Q1 2021 May 12, 2021	BUY	$547.01 - $662.35 $15,316 - $18,545	28 Added 1.59%	1,792 $1.02 Million
Q4 2020 Feb 12, 2021	SELL	$510.68 - $643.45 $15,320 - $19,303	-30 Reduced 1.67%	1,764 $1.03 Million
Q3 2020 Nov 12, 2020	BUY	$454.43 - $535.6 $10,906 - $12,854	24 Added 1.36%	1,794 $925,000
Q2 2020 Aug 12, 2020	BUY	$334.87 - $493.06 $592,719 - $872,716	1,770 New	1,770 $799,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

Stay updated on Norinchukin Bank, The with notifications on news.